Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pileri

Showing results (201-210 of 524) with videos related to

Pageof 53
Sort By:
Leukemia & Lymphoma|June 28, 2001
Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autograftingM Ladetto, S Sametti, M Astolfi, et al.
Blood Cancer Journal|September 9, 2017
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directionsC A van der Weyden, S A Pileri, A L Feldman, et al.
The Lancet. Haematology|February 5, 2017
Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma - Authors' replyClaudio Agostinelli, Andrea Gallamin, Fabio Fuligni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2022
BCL-2 expression in primary cutaneous follicle center lymphoma is associated with a higher risk of cutaneous relapses: A study of 126 casesA Pileri, V Grandi, C Agostinelli, et al.
Current Hematologic Malignancy Reports|August 7, 2010
Prognostic markers in peripheral T-cell lymphomaPier Paolo Piccaluga, Claudio Agostinelli, Anna Gazzola, et al.
The Lancet. Oncology|June 1, 2005
Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specifiedPier Paolo Piccaluga, Claudio Agostinelli, Pier Luigi Zinzani, et al.
Haematologica|September 1, 1991
Phenotypic and functional analysis of peripheral blood lymphocytes during interferon-alpha 2b therapy in multiple myeloma patients with low tumor massA Bianchi, P Omedé, C Attisano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling indexM Boccadoro, A Gallamini, A Fruttero, et al.
Critical Reviews in Oncology/Hematology|February 5, 2013
Diffuse large B-cell lymphomaMaurizio Martelli, Andrés J M Ferreri, Claudio Agostinelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2018
Primary cutaneous small/medium-sized pleomorphic T-cell lymphoproliferative disorder shows a common vascular pattern at dermoscopyA Pileri, C Agostinelli, E Sabattini, et al.
Pageof 53

Showing results (201-210 of 524) with videos related to

Sort By:
Pageof 53
Leukemia & Lymphoma|June 28, 2001
Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autograftingM Ladetto, S Sametti, M Astolfi, et al.
Blood Cancer Journal|September 9, 2017
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directionsC A van der Weyden, S A Pileri, A L Feldman, et al.
The Lancet. Haematology|February 5, 2017
Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma - Authors' replyClaudio Agostinelli, Andrea Gallamin, Fabio Fuligni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2022
BCL-2 expression in primary cutaneous follicle center lymphoma is associated with a higher risk of cutaneous relapses: A study of 126 casesA Pileri, V Grandi, C Agostinelli, et al.
Current Hematologic Malignancy Reports|August 7, 2010
Prognostic markers in peripheral T-cell lymphomaPier Paolo Piccaluga, Claudio Agostinelli, Anna Gazzola, et al.
The Lancet. Oncology|June 1, 2005
Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specifiedPier Paolo Piccaluga, Claudio Agostinelli, Pier Luigi Zinzani, et al.
Haematologica|September 1, 1991
Phenotypic and functional analysis of peripheral blood lymphocytes during interferon-alpha 2b therapy in multiple myeloma patients with low tumor massA Bianchi, P Omedé, C Attisano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling indexM Boccadoro, A Gallamini, A Fruttero, et al.
Critical Reviews in Oncology/Hematology|February 5, 2013
Diffuse large B-cell lymphomaMaurizio Martelli, Andrés J M Ferreri, Claudio Agostinelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2018
Primary cutaneous small/medium-sized pleomorphic T-cell lymphoproliferative disorder shows a common vascular pattern at dermoscopyA Pileri, C Agostinelli, E Sabattini, et al.
Pageof 53